Pharmaceuticals Bayer: Science For A Better Life

You need commitment, focus and passion to find new ways to fight the diseases of this world: innovation is at the heart of it.

Partnering

Partnering
orange

Innovation + Partnering

The future of cancer therapy is now
orange

Treatment + Care

Cancer is 100 diseases and each patient is unique
blue

Commitment + Responsibility

We support the EFPIA campaign
#WeWontRest
green

Innovation + Partnering

From molecules to medicine
Drug development: The R&D journey
orange
Cancer

Cancer
blue
Healthy aging

Healthy aging
green
Health policy

Health policy
green

Innovation + Partnering

Open science in cancer research: everybody wins
orange

Argentina

Chagas Disease

“We believe Chagas is a children’s disease”, Dr Jaime Altcheh says, formulating an altogether radical theory about one of the greatest scourges to afflict Latin America.
Social Channels

FaCEBOOK·14 hours

#healthyaging… it starts with nutrition. You care for a patient suffering from sickness, nausea or having problems with chewing or swallowing? Cook this hearty vegetable stew for healthy vitamins, minerals and fibres. Learn more about our commitment to #healthyaging here: bit.ly/HealthyBayer

twitter·2 days

#WCGIC Answer to our earlier #Quiz: The #liver is located under the right rib. It has several important functions:

youtube·6 months

The toughest interview for Clinician Scientists
Visit us on Facebook
Visit us on Twitter
Visit us on YouTube
Bayer sponsored clinical studies

Treatment + Care

Bayer trial finder

www.clinicaltrials.gov

Clinicaltrials.gov

www.clinicalstudydatarequest.com

Data sharing portal

Latest press release

Find us in your country

News

2018-06-01

Bayer and MD Anderson Cancer Center to collaborate on development of novel cancer treatments

2018-05-29

U.S. FDA accepts larotrectinib New Drug Application and grants priority review

2018-05-17

Bayer highlights latest oncology research at ASCO 2018

2018-05-11

Bayer receives approval for Eylea® in China

2018-05-03

Bayer: Operational business held back by currency effects – Major progress with Monsanto acquisition
Press center